Hussman Strategic Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-15,600
| Closed | -$201K | – | 332 |
|
|
2022
Q1 | $201K | Hold |
15,600
| – | – | 0.04% | 291 |
|
|
2021
Q4 | $249K | Sell |
15,600
-20,400
| -57% | -$326K | 0.05% | 289 |
|
|
2021
Q3 | $579K | Hold |
36,000
| – | – | 0.13% | 221 |
|
|
2021
Q2 | $498K | Hold |
36,000
| – | – | 0.1% | 263 |
|
|
2021
Q1 | $526K | Buy |
+36,000
| New | +$526K | 0.11% | 251 |
|